Surfactant
WHO आवश्यक दवा EML अनुभाग: Medicines administered to the neonate
यह केवल जानकारी है, प्रिस्क्रिप्शन नहीं। कोई भी दवा लेने से पहले डॉक्टर या फार्मासिस्ट से सलाह लें। ओवरडोज़/विषाक्तता पर 102 पर कॉल करें।
Nepal brand names not included: no licence-safe source.
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.
None
What is Beractant used for?
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
What are the side effects of Beractant?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.
Who should not take Beractant?
None
What is the dose of Beractant?
Not provided here. Ask a doctor or pharmacist.
Beractant क्या है?
Beractant is used for: SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants. It belongs to the class: Surfactant. Common side effects include: The occurrence of concurrent illnesses common in premature infants was evaluat…
Beractant के दुष्प्रभाव क्या हैं?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.
स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm